Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Horowitz

Showing results (161-170 of 219) with videos related to

Pageof 22
Sort By:
Therapeutic Drug Monitoring|March 9, 2011
Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexilineLiang-Han Ling, William Chik, Paula Averbuj, et al.
Current Cardiology Reviews|June 10, 2016
Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian AboriginesPupalan Iyngkaran, Nadarajan Kangaharan, Hendrik Zimmet, et al.
European Journal of Heart Failure|June 25, 2013
No association of G-protein-coupled receptor kinase 5 or β-adrenergic receptor polymorphisms with Takotsubo cardiomyopathy in a large Australian cohortGemma A Figtree, Richard D Bagnall, Irfan Abdulla, et al.
International Journal of Cardiology|November 15, 2011
Navigating the fine line between benefit and risk in chronic atrial fibrillation: rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)Melinda J Carrington, Jocasta Ball, John D Horowitz, et al.
Diabetes & Vascular Disease Research|November 25, 2005
Platelet nitrate responsiveness in fasting and postprandial type 2 diabetesRichard A Anderson, Gethin R Ellis, L Marc Evans, et al.
Plos One|March 19, 2013
Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trialJennifer A Whitty, Simon Stewart, Melinda J Carrington, et al.
Journal of Cardiovascular Development and Disease|July 28, 2023
Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac FunctionConagh J Kelly, Matthew Chu, Rossana Untaru, et al.
Cardiovascular Drugs and Therapy|August 8, 2013
Enhanced NO signaling in patients with Takotsubo cardiomyopathy: short-term pain, long-term gain?Thanh H Nguyen, Christopher J Neil, Aaron L Sverdlov, et al.
Cardiovascular Drugs and Therapy|August 5, 2014
Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesCher-Rin Chong, Wai Ping A Chan, Thanh H Nguyen, et al.
Trials|January 13, 2016
Cardiovascular Health in Anxiety or Mood Problems Study (CHAMPS): study protocol for a randomized controlled trialPhillip J Tully, Deborah A Turnbull, John D Horowitz, et al.
Pageof 22

Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Therapeutic Drug Monitoring|March 9, 2011
Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexilineLiang-Han Ling, William Chik, Paula Averbuj, et al.
Current Cardiology Reviews|June 10, 2016
Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian AboriginesPupalan Iyngkaran, Nadarajan Kangaharan, Hendrik Zimmet, et al.
European Journal of Heart Failure|June 25, 2013
No association of G-protein-coupled receptor kinase 5 or β-adrenergic receptor polymorphisms with Takotsubo cardiomyopathy in a large Australian cohortGemma A Figtree, Richard D Bagnall, Irfan Abdulla, et al.
International Journal of Cardiology|November 15, 2011
Navigating the fine line between benefit and risk in chronic atrial fibrillation: rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)Melinda J Carrington, Jocasta Ball, John D Horowitz, et al.
Diabetes & Vascular Disease Research|November 25, 2005
Platelet nitrate responsiveness in fasting and postprandial type 2 diabetesRichard A Anderson, Gethin R Ellis, L Marc Evans, et al.
Plos One|March 19, 2013
Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trialJennifer A Whitty, Simon Stewart, Melinda J Carrington, et al.
Journal of Cardiovascular Development and Disease|July 28, 2023
Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac FunctionConagh J Kelly, Matthew Chu, Rossana Untaru, et al.
Cardiovascular Drugs and Therapy|August 8, 2013
Enhanced NO signaling in patients with Takotsubo cardiomyopathy: short-term pain, long-term gain?Thanh H Nguyen, Christopher J Neil, Aaron L Sverdlov, et al.
Cardiovascular Drugs and Therapy|August 5, 2014
Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesCher-Rin Chong, Wai Ping A Chan, Thanh H Nguyen, et al.
Trials|January 13, 2016
Cardiovascular Health in Anxiety or Mood Problems Study (CHAMPS): study protocol for a randomized controlled trialPhillip J Tully, Deborah A Turnbull, John D Horowitz, et al.
Pageof 22